General
Mobile virus test could help cut cervical cancer-linked deaths
 

Mobile virus test could help cut cervical cancer-linked deaths

Shared by:

 
A mobile diagnostic test that can detect the human papillomavirus (HPV), the leading cause of cervical and other genital cancers, is being developed by United Kingdom-based biotechnology company QuantumMDx and non-governmental organisation Global Good. The test aims to allow patients to perform a self-test at home by taking a pinprick of blood through the point-of-care diagnostic device. At this stage of its development and testing, the sample-to-result time is under 20 minutes. “The HPV assay works towards the gold standard, pap smears that are currently used in developed countries,” QuantumDx executive director Eunice Teo told TODAY. The diagnostic tool is hoped to be a low-cost solution for screening and treating women in low and middle-income countries. “By placing (such) diagnostics tools ... in the hands of health workers, it empowers them to monitor and provide (high-risk HPV-positive) women in (those countries) with the same access to early detection that has dramatically reduced cervical cancer-related deaths in higher-income countries,” said Ms Teo. AMANDA LEE
 
www.todayonline.com
 
24 Jul 2017 - General